Heart failure: a major public health problem
Presse Med. 2024 Feb 8:104224. doi: 10.1016/j.lpm.2024.104224. Online ahead of print.NO ABSTRACTPMID:38340897 | DOI:10.1016/j.lpm.2024.104224 (Source: Presse Medicale)
Source: Presse Medicale - February 10, 2024 Category: General Medicine Authors: Claude Daubert Source Type: research

Towards etiological treatments in cardiomyopathies
Presse Med. 2024 Feb 1:104223. doi: 10.1016/j.lpm.2024.104223. Online ahead of print.ABSTRACTThis review proposes to look at the evolution of cardiomyopathy treatments in the light of advances in diagnostic techniques, which have enabled to move from a mechanistic to a phenotypic and then etiological approach. The article goes beyond the ejection fraction approach, and look at new therapies that target the pathophysiological pathways of cardiomyopathies, either by targeting the phenotype, or by targeting the etiology. The evolution of HCM treatments is detailed, culminating in the latest etiological treatments such as mava...
Source: Presse Medicale - February 3, 2024 Category: General Medicine Authors: Olivier Lairez Pauline Fournier Romain Itier B érengère Bachelet Antoine Huart Eve Cariou Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akram Missaoui Fadoua Neili Bilel Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akrem Neili Bilel Missaoui Fadoua Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akrem Neili Bilel Missaoui Fadoua Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akrem Neili Bilel Missaoui Fadoua Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akrem Neili Bilel Missaoui Fadoua Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
In conclusion, the results associated with the TH17/TREG scale and their correlations with fibrosis in systemic sclerosis open a way for new tools to manage this autoimmune disease, which up to today has neither treatment nor accurate diagnosis.PMID:38161053 | DOI:10.1016/j.lpm.2023.104221 (Source: Presse Medicale)
Source: Presse Medicale - December 31, 2023 Category: General Medicine Authors: Gabsi Amira Dlala Akrem Neili Bilel Missaoui Fadoua Boutaba Alya Ben Salem Khalil Smiti Khanfir Monia Said Fatma Houman Mohamed Habib Bardin Nathalie Triki Marrakchi Raja Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research

All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research